Abstract PS2-07-13: Prognostic and predictive role of RBsig and CCNE1/RB1 gene-expression signatures for patients with early breast cancer treated with endocrine therapy with or without palbociclib in the PALLAS trial (ABCSG-42, AFT-05, BIG 14-03)
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Authors: L. Malorni, D. Hlauschek, E. Mayer, M. Benelli, L. Biganzoli, I. Migliaccio, A. Kermanidis, G. Pfeiler, E. P. Mamounas, A. M. Brufsky, M. Bellet-Ezquerra, K. Clifton, G. Rubovszky, T. Foukakis, M. Goetz, S. Lee, M. Ruiz-Borrego, W. Symmans, K. V. Ballman, F. Liu, J. Machacek-Link, C. Denkert, A. DeMichele, M. Gnant
Institutions: Azienda Usl Toscana Centro, Hospital of Prato, Austrian Breast & Colorectal Cancer Study Group, Dana-Farber Cancer Institute, University of Florence, Medical University of Vienna, Orlando Health, UPMC Hillman Cancer Center, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology, Washington University in St. Louis, National Institute of Oncology, Karolinska Institutet, Mayo Clinic, National University Cancer Institute, Singapore, Hospital Universitario Virgen del Rocío, GEICAM – Spanish Breast Cancer Group, The University of Texas MD Anderson Cancer Center, Pfizer (United States), Philipps University of Marburg, Universitätsklinikum Gießen und Marburg, University of Pennsylvania, Comprehensive Cancer Center Vienna
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7129598224
Cites:
Cited by:
Related to: